HAVENCREST CAPITAL MANAGEMENT, LLC
HAVENCREST CAPITAL MANAGEMENT, LLC is a Series C+ and buyout fund in the US writing $25M–$250M checks into Healthcare and healthcare-tech.
- Stages
- Series C+, buyout
- Sectors
- Healthcare, healthcare-tech
- Check size
- $25M–$250M
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2018
- Assets under management
- >$600M
- Website
- havencrest.com
Thesis
Havencrest Capital Management, LLC is a private equity firm founded in 2018 and based in Dallas, Texas, with an exclusive focus on the healthcare industry. The firm targets founder-led, high-growth, and market-leading healthcare companies, particularly in the lower middle market. Their investment strategy involves acquiring founder-owned healthcare companies with EBITDA typically between $3 million and $15 million, and enterprise values ranging from $25 million to $250 million. Havencrest primarily invests in growth-stage and recapitalization companies through buyouts, with a geographic focus on the United States. They partner with management teams to drive value through operational improvements and M&A growth initiatives. The firm closed its second fund, Havencrest Healthcare Partners II, L.P., at $356 million in April 2022, and its total AUM exceeds $600 million.
Common questions
Does HAVENCREST CAPITAL MANAGEMENT, LLC invest at the Series C+ stage?
Yes. HAVENCREST CAPITAL MANAGEMENT, LLC lists Series C+ and buyout among the stages it invests in.
What check size does HAVENCREST CAPITAL MANAGEMENT, LLC write?
HAVENCREST CAPITAL MANAGEMENT, LLC writes $25M–$250M checks.
Where does HAVENCREST CAPITAL MANAGEMENT, LLC invest?
HAVENCREST CAPITAL MANAGEMENT, LLC invests in the US.